A real-world adverse events study of rimegepant from the FAERS database
This study highlights previously unrecognized safety concerns associated with the use of rimegepant. These novel safety aspects suggest that while these treatments can be effective, additional risks may need further exploration.
Authors
- Shasha Lin (ORCID: https://orcid.org/0000-0001-5446-8133)
- Hong Pan (ORCID: https://orcid.org/0000-0002-0539-7997)
Institutions
- Harbin Medical University (CN)
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Wuqing District People's Hospital (CN)
- Daqing City People's Hospital (CN)
- People’s Hospital of Linqing (CN)
- Yueqing People's Hospital (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1080/14740338.2024.2418319
- Citations
- 3
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.16